Candriam SCA’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-58,427
| Closed | -$695K | – | 843 |
|
|
2022
Q1 | $695K | Hold |
58,427
| – | – | ﹤0.01% | 712 |
|
|
2021
Q4 | $1.91M | Hold |
58,427
| – | – | 0.01% | 552 |
|
|
2021
Q3 | $2.61M | Hold |
58,427
| – | – | 0.02% | 519 |
|
|
2021
Q2 | $3.18M | Buy |
+58,427
| New | +$3.18M | 0.02% | 491 |
|
|
2019
Q4 | – | Sell |
-16,900
| Closed | -$1.75M | – | 809 |
|
|
2019
Q3 | $1.75M | Hold |
16,900
| – | – | 0.02% | 517 |
|
|
2019
Q2 | $1.56M | Sell |
16,900
-3,500
| -17% | -$323K | 0.02% | 566 |
|
|
2019
Q1 | $1.87M | Hold |
20,400
| – | – | 0.02% | 514 |
|
|
2018
Q4 | $1.14M | Hold |
20,400
| – | – | 0.02% | 565 |
|
|
2018
Q3 | $2.43M | Hold |
20,400
| – | – | 0.03% | 459 |
|
|
2018
Q2 | $2.08M | Hold |
20,400
| – | – | 0.03% | 476 |
|
|
2018
Q1 | $2.65M | Sell |
20,400
-600
| -3% | -$77.9K | 0.05% | 415 |
|
|
2017
Q4 | $2.04M | Buy |
21,000
+9,000
| +75% | +$876K | 0.04% | 447 |
|
|
2017
Q3 | $1.77M | Buy |
+12,000
| New | +$1.77M | 0.03% | 480 |
|